📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Telavant

1.1 - Company Overview

Telavant Logo

Telavant

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel medicines in development to assist patients suffering from inflammatory and fibrotic disorders.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Telavant

Epirus Biopharma Logo

Epirus Biopharma

HQ: United States Website
  • Description: Provider of biosimilar monoclonal antibodies and therapeutic proteins for emerging markets.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Epirus Biopharma company profile →
Viridian Therapeutics Logo

Viridian Therapeutics

HQ: United States Website
  • Description: Provider of treatments for patients suffering from diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Viridian Therapeutics company profile →
Reneo Pharmaceuticals Logo

Reneo Pharmaceuticals

HQ: United States Website
  • Description: Provider of therapies in development for rare genetic mitochondrial and orphan metabolic diseases. Develops mavodelpar (REN001) for primary mitochondrial myopathies (PMM) and long-chain fatty acid oxidation disorders (LC-FAOD), with a global Phase 2b trial in PMM and completed exploratory Phase 1b trials in LC-FAOD and McArdle disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Reneo Pharmaceuticals company profile →
Sudo Biosciences Logo

Sudo Biosciences

HQ: United States Website
  • Description: Provider of TYK2 pseudokinase domain–targeting medicines, including a brain-penetrant TYK2 inhibitor for multiple sclerosis and neurodegenerative diseases, and a topical TYK2 inhibitor for psoriasis and other immune-mediated dermatologic conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sudo Biosciences company profile →
EpiBiologics Logo

EpiBiologics

HQ: United States Website
  • Description: Provider of antibody-based targeted therapies and platforms for tissue-specific degradation of disease-driving membrane and extracellular proteins, including the EpiTAC platform (bispecific antibody system), AbTACs, KineTACs, TrainTAC degrader, and the EpiAtlas platform with a library of over 270 degrader arms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full EpiBiologics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Telavant

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Telavant

2.2 - Growth funds investing in similar companies to Telavant

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Telavant

4.2 - Public trading comparable groups for Telavant

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Telavant

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Telavant

What does Telavant do?

Telavant is a provider of novel medicines in development to assist patients suffering from inflammatory and fibrotic disorders.

Who are Telavant's competitors?

Telavant's competitors and similar companies include Epirus Biopharma, Viridian Therapeutics, Reneo Pharmaceuticals, Sudo Biosciences, and EpiBiologics.

Where is Telavant headquartered?

Telavant is headquartered in United States.

How many employees does Telavant have?

Telavant has 1,000 employees 🔒.

When was Telavant founded?

Telavant was founded in 2010 🔒.

What sector and industry vertical is Telavant in?

Telavant is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Telavant

Who are the top strategic acquirers in Telavant's sector and industry

Top strategic M&A buyers and acquirers in Telavant's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Telavant?

Top strategic M&A buyers groups and sectors for Telavant include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Telavant's sector and industry vertical

Which are the top PE firms investing in Telavant's sector and industry vertical?

Top PE firms investing in Telavant's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Telavant's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Telavant's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Telavant's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Telavant include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Telavant's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Telavant?

The key public trading comparables and valuation benchmarks for Telavant include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Telavant for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Telavant with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Telavant's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Telavant with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Telavant's' sector and industry vertical?

Access recent funding rounds and capital raises in Telavant's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Telavant